about
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodys...
Read More
7.20
0.12
(1.69%)
18,473
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Mid Valuation
Technically Neutral
Kyntra Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..